ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,635,000 | -11.0% | 236,456 | +7.8% | 0.00% | -33.3% |
| Q3 2021 | $7,453,000 | -14.9% | 219,269 | +2.3% | 0.01% | -14.3% |
| Q2 2021 | $8,760,000 | +28.3% | 214,394 | +26.4% | 0.01% | +40.0% |
| Q1 2021 | $6,829,000 | -39.0% | 169,627 | -10.4% | 0.01% | -44.4% |
| Q4 2020 | $11,195,000 | +44.6% | 189,335 | +18.9% | 0.01% | +28.6% |
| Q3 2020 | $7,742,000 | +10.5% | 159,200 | +9.9% | 0.01% | 0.0% |
| Q2 2020 | $7,005,000 | +685.3% | 144,800 | +351.1% | 0.01% | +600.0% |
| Q1 2020 | $892,000 | +3.5% | 32,100 | +11.5% | 0.00% | 0.0% |
| Q4 2019 | $862,000 | – | 28,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |